These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8063740)

  • 21. Enhancement of tissue-type plasminogen activator (t-PA) activity by purified t-PA receptor expressed in human endothelial cells.
    Fukao H; Ueshima S; Takaishi T; Okada K; Matsuo O
    Biochim Biophys Acta; 1997 Mar; 1356(1):111-20. PubMed ID: 9099997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombin decreases the urokinase receptor and surface-localized fibrinolysis in cultured endothelial cells.
    Li XN; Varma VK; Parks JM; Benza RL; Koons JC; Grammer JR; Grenett H; Tabengwa EM; Booyse FM
    Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):410-9. PubMed ID: 7749851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of receptors for plasminogen activators on endothelial cell surface depends on their origin.
    Kwaan HC; Wang J; Weiss I
    J Thromb Haemost; 2004 Feb; 2(2):306-12. PubMed ID: 14995994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
    Sharma MR; Rothman V; Tuszynski GP; Sharma MC
    Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
    Barnathan ES; Kuo A; Rosenfeld L; Karikó K; Leski M; Robbiati F; Nolli ML; Henkin J; Cines DB
    J Biol Chem; 1990 Feb; 265(5):2865-72. PubMed ID: 2154462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
    Bakker AH; Nieuwenbroek NM; Verheijen JH
    Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New insights into the tPA-annexin A2 interaction. Is annexin A2 CYS8 the sole requirement for this association?
    Roda O; Valero ML; Peiró S; Andreu D; Real FX; Navarro P
    J Biol Chem; 2003 Feb; 278(8):5702-9. PubMed ID: 12468550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction of recombinant tissue type plasminogen activator and recombinant plasminogen activator (r-PA/BM 06.022) with human endothelial cells.
    Mulder M; Kohnert U; Fischer S; van Hinsbergh VW; Verheijen JH
    Blood Coagul Fibrinolysis; 1997 Mar; 8(2):124-33. PubMed ID: 9518044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor.
    Hajjar KA
    J Clin Invest; 1993 Jun; 91(6):2873-9. PubMed ID: 8390492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profibrinolytic properties characterize a stably transformed human endothelial cell line.
    Camera M; Hajjar KA; Pan S; Szabo P; Vicart P; Paulin D; Weksler BB
    Blood Coagul Fibrinolysis; 1998 Mar; 9(2):153-65. PubMed ID: 9622213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.
    Sharma MC; Sharma M
    Curr Pharm Des; 2007; 13(35):3568-75. PubMed ID: 18220793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation.
    Kost C; Stüber W; Ehrlich HJ; Pannekoek H; Preissner KT
    J Biol Chem; 1992 Jun; 267(17):12098-105. PubMed ID: 1376317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is diabetic hypercoagulability an acquired annexinopathy? Glycation of annexin II as a putative mechanism for impaired fibrinolysis in diabetic patients.
    Gugliucci A; Ghitescu L
    Med Hypotheses; 2002 Sep; 59(3):247-51. PubMed ID: 12208147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of annexin II tetramer in the activation of plasminogen.
    Kassam G; Choi KS; Ghuman J; Kang HM; Fitzpatrick SL; Zackson T; Zackson S; Toba M; Shinomiya A; Waisman DM
    J Biol Chem; 1998 Feb; 273(8):4790-9. PubMed ID: 9468544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The endothelial cell tissue plasminogen activator receptor. Specific interaction with plasminogen.
    Hajjar KA
    J Biol Chem; 1991 Nov; 266(32):21962-70. PubMed ID: 1657983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of tissue plasminogen activator to endothelial cells. The effect on functional properties. Localization of a ligand in the B-chain of tPA.
    Cheng XF; Brohlin M; Pohl G; Bäck O; Wallén P
    Thromb Res; 1995 Jan; 77(2):149-64. PubMed ID: 7740507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A linear amino acid sequence involved in the interaction of t-PA with its endothelial cell receptor.
    Beebe DP; Miles LA; Plow EF
    Blood; 1989 Nov; 74(6):2034-7. PubMed ID: 2478220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of binding protein for tissue-type plasminogen activator in human endothelial cells.
    Fukao H; Hagiya Y; Nonaka T; Okada K; Matsuo O
    Biochem Biophys Res Commun; 1992 Sep; 187(2):956-62. PubMed ID: 1326962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of wild-type and catalytically inactive mutant forms of tissue-type plasminogen activator with human umbilical vein endothelial cell monolayers.
    Ramakrishnan V; Sinicropi DV; Dere R; Darbonne WC; Bechtol KB; Baker JB
    J Biol Chem; 1990 Feb; 265(5):2755-62. PubMed ID: 2105933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
    Lobov S; Croucher DR; Saunders DN; Ranson M
    Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.